Sanofi (BKK:SANOFI80)

Market Cap	3.59T -19.6%
Revenue (ttm)	1.73T +5.5%
Net Income	289.30B +40.5%
EPS	237.06 +44.2%
Shares Out	n/a
PE Ratio	12.42
Forward PE	9.61
Dividend	0.10 (3.48%)
Ex-Dividend Date	May 13, 2025

Volume	68,135
Average Volume	203,162
Open	3.000
Previous Close	2.980
Day's Range	2.980 - 3.040
52-Week Range	2.820 - 4.100
Beta	n/a
RSI	48.27
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: SANOFI80

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR